ASK REDCHAT ANYTHING ABOUT BARINTHUS BIOTHERAPEUTICS PLC
Barinthus Biotherapeutics plc (NASDAQ: BRNS)
Listen to this Section
$0.68
-0.0208
(
-2.97% )
2.5K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| VTP-300 +/- NivolumabDetailsChronic hepatitis B |
Phase 2b |
| VTP-300 + AB-729DetailsChronic hepatitis B |
Phase 2a |
| VTP-600DetailsNon-small cell lung carcinoma |
Phase 1/2 |
| VTP-850DetailsHuman papillomavirus, Cancer, Prostate cancer |
Phase 1/2 |
| VTP-200DetailsHuman papillomavirus |
Phase 1/2 |
| VTP-1000DetailsCeliac disease |
Phase 1 |
Market Data
|
| Open |
$0.68 |
| Previous Close |
$0.70 |
| Volume |
2.5K |
| Market Cap |
$28.63M |
| Day Range |
$0.65 - $0.68 |
| 52 Week Range |
$0.51 - $2.92 |
| Shares Outstanding |
40.85M |
| Change % |
-2.97% |
| Net Change |
▼ -0.0208 |
| Insider Ownership |
-0.03% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2021 |
| Country | United Kingdom |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-1,150,743.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-06-18 |
Sale |
-195166.00 |
Hooftman Leon |
| 2024-05-14 |
Sale |
-19516.00 |
DAWES KAREN A |
| 2024-05-14 |
Sale |
-19516.00 |
Scheeren Joseph |
| 2024-05-14 |
Sale |
-19516.00 |
Phillips Anne M. |
| 2024-05-14 |
Sale |
-19516.00 |
Hammacher Alex |
| 2024-05-14 |
Sale |
-19516.00 |
Morgon Pierre A. |
| 2024-05-14 |
Sale |
-19516.00 |
Wright Robin |
| 2024-01-04 |
Sale |
-105000.00 |
Pelletier Nadege |
| 2024-01-04 |
Sale |
-96500.00 |
Griffiths Graham |
| 2024-01-04 |
Sale |
-443981.00 |
Enright William |